Boston Scientific is recalling 41,191 ACCOLADE family pacemakers and Visionist and Valitude CRT-P devices worldwide. The software to enhance Safety Architecture could prevent Safety Mode activation in ambulatory settings when a high battery impedance state is present. Patients should stop using the device and contact their healthcare provider for instructions.
Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps).
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Boston Scientific Corporation or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Pacemakers regulate heart rhythm and are implanted in patients to manage arrhythmias. CRT-P devices like Visionist and Valitude are used to synchronize heart chambers in certain conditions. This recall covers multiple BAC devices under the ACCOLADE family and these CRT-P models.
A software upgrade intended to improve Safety Architecture could inadvertently prevent Safety Mode from activating if a high battery impedance state occurs, potentially compromising device safety.
This recall is not described as part of a broader industry pattern in the notice.
Patients with affected devices could face safety risks if the device fails to enter required safety modes. Immediate action is advised through medical professionals to determine next steps.
Recall letters, FDA enforcement report, and manufacturer communications include identifiers, steps, and contact information.
Not specified in the recall notice. Healthcare providers will coordinate replacements or other actions.
Document recall notice, device model/serial numbers, clinician communications, and any replacement actions.
Model numbers: U228, VISIONIST CRT-P EL MRI. Devices affected include ACCOLADE family devices (ACCOLADE, PROPONENT, ESSENTIO, ALTRUA 2 dual chamber DR SL and DR EL) and VISIONIST and VALITUDE CRT-Ps. GTIN: 00802526559471. Serial numbers: 726570, 728246, 728341, 728391, 728414, 728416, 728463, 728492, 728880, 732912, 733290, 733427, 733464, 733475, 733541, 733672, 733700, 733703, 733748. Distribution: Worldwide. Quantity: 41,191 units. Sold at: Unknown. Price: Unknown.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Boston Scientific is recalling 806 EndoVive Safety PEG Kits sold nationwide. The recall concerns BD ChloraPrep Triple Swabsticks with open or compromised seals that could compromise sterility or dry the antiseptic solution. Hospitals and patients should stop using the kits immediately and follow the manufacturer's recall instructions.
Boston Scientific recalled 150 units of its *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. The recall follows increased reports of stent deployment and expansion issues, which could lead to serious medical interventions. Healthcare providers and patients must stop using the device immediately.
Boston Scientific recalled 588 units of its *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. The recall follows multiple reports of stent deployment and expansion issues, posing serious risks during medical procedures.
Boston Scientific recalled 557 units of the AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. Increased reports of stent deployment and expansion issues prompted this recall. The defect may require additional medical intervention to resolve deployment failures.
Boston Scientific recalled 59 AXIOS Stents on December 19, 2025. Increased reports of deployment and expansion issues pose serious risks during procedures. Users should stop using the devices immediately and follow recall instructions.
Boston Scientific recalled 39 AXIOS Stent and Electrocautery-Enhanced Delivery Systems on December 19, 2025. Reports indicated issues with stent deployment and expansion, potentially leading to additional surgical interventions. The recall affects units distributed worldwide, including the United States and several other countries.
Boston Scientific recalled 266 units of the HOT AXIOS Stent on December 19, 2025. Reports indicated deployment and expansion problems, posing risks of prolonged procedures and additional surgical interventions. Consumers must stop using the device immediately and follow the manufacturer's instructions.
Boston Scientific recalled 21,000 Coyote Over-the-Wire PTA Balloon Dilation Catheters on December 3, 2025. The recall affects devices that may not properly inflate or deflate, posing a risk during medical procedures. Patients and healthcare providers should stop using these devices immediately and follow the recall instructions.